2024 Q1 Form 10-K Financial Statement
#000149315224009954 Filed on March 14, 2024
Income Statement
Concept | 2024 Q1 | 2023 Q4 | 2023 Q2 |
---|---|---|---|
Revenue | $11.27M | $6.952M | $2.186M |
YoY Change | 72.62% | 41.7% | -158.86% |
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $4.146M | $2.441M | $2.332M |
YoY Change | 62.78% | 4.09% | 2.78% |
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $317.0K | $200.0K | |
YoY Change | 19.17% | ||
% of Gross Profit | |||
Operating Expenses | $14.58M | $7.162M | $5.109M |
YoY Change | 181.53% | 50.05% | 7.72% |
Operating Profit | -$5.932M | -$6.206M | |
YoY Change | 43.67% | ||
Interest Expense | $225.0K | -$1.698M | |
YoY Change | -91.6% | -44.69% | |
% of Operating Profit | |||
Other Income/Expense, Net | $1.795M | -$92.00K | |
YoY Change | 5509.38% | ||
Pretax Income | -$4.137M | -$210.0K | -$2.923M |
YoY Change | -406.44% | -257.89% | -46.64% |
Income Tax | $116.0K | -$14.00K | |
% Of Pretax Income | |||
Net Earnings | -$4.445M | -$657.0K | -$2.923M |
YoY Change | -429.26% | 109.24% | -46.64% |
Net Earnings / Revenue | -39.45% | -9.45% | -133.71% |
Basic Earnings Per Share | -$0.27 | -$0.54 | |
Diluted Earnings Per Share | -$0.27 | -$0.06 | -$0.35 |
COMMON SHARES | |||
Basic Shares Outstanding | 28.37M shares | 10.56M shares | 9.439M shares |
Diluted Shares Outstanding | 16.74K shares | 9.705M shares |
Balance Sheet
Concept | 2024 Q1 | 2023 Q4 | 2023 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $7.209M | $2.396M | $2.962M |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | $4.446M | $4.079M | |
Prepaid Expenses | |||
Receivables | $6.285M | $6.477M | |
Other Receivables | |||
Total Short-Term Assets | |||
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $4.286M | $12.22M | $48.00K |
YoY Change | 8142.31% | 21721.43% | -99.93% |
Goodwill | $881.0K | $903.0K | |
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $23.95M | $23.53M | $25.78M |
YoY Change | -12.84% | -8.36% | 135.97% |
Other Assets | $21.57M | $10.61M | |
YoY Change | 132.72% | 44.68% | |
Total Long-Term Assets | |||
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | |||
Total Long-Term Assets | |||
Total Assets | $110.3M | $65.74M | $48.57M |
YoY Change | 120.54% | 32.87% | 30.3% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $206.0K | $508.0K | |
YoY Change | -71.51% | 29.59% | |
Accrued Expenses | $48.00K | ||
YoY Change | -99.93% | ||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $4.592M | $4.732M | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $206.0K | $556.0K | |
YoY Change | -71.51% | 41.84% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | ||
YoY Change | |||
Other Long-Term Liabilities | $93.00K | $546.0K | $116.0K |
YoY Change | -51.05% | 142.67% | -0.85% |
Total Long-Term Liabilities | $93.00K | $546.0K | $116.0K |
YoY Change | -51.05% | 142.67% | -0.85% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $206.0K | $556.0K | |
Total Long-Term Liabilities | $93.00K | $546.0K | $116.0K |
Total Liabilities | $43.68M | $23.24M | $11.56M |
YoY Change | 290.06% | 90.84% | 20.91% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$2.161M | -$33.15M | -$37.67M |
YoY Change | -93.7% | -5.56% | -15.53% |
Common Stock | $28.00K | $10.00K | $10.00K |
YoY Change | 211.11% | 11.11% | 11.11% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $18.59M | ||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $64.80M | $42.49M | $37.01M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $110.3M | $65.74M | $48.57M |
YoY Change | 120.54% | 32.87% | 30.3% |
Cashflow Statement
Concept | 2024 Q1 | 2023 Q4 | 2023 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$4.445M | -$657.0K | -$2.923M |
YoY Change | -429.26% | 109.24% | -46.64% |
Depreciation, Depletion And Amortization | $317.0K | $200.0K | |
YoY Change | 19.17% | ||
Cash From Operating Activities | -$1.030M | -$2.147M | |
YoY Change | -237.33% | 5863.89% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | ||
YoY Change | -100.0% | ||
Acquisitions | $1.800M | ||
YoY Change | |||
Other Investing Activities | $44.00K | ||
YoY Change | -95.95% | ||
Cash From Investing Activities | $2.234M | $44.00K | |
YoY Change | 143.62% | -95.73% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -$634.0K | 761.0K | |
YoY Change | 69.97% | -77.2% | |
NET CHANGE | |||
Cash From Operating Activities | -$1.030M | -2.147M | |
Cash From Investing Activities | $2.234M | 44.00K | |
Cash From Financing Activities | -$634.0K | 761.0K | |
Net Change In Cash | $565.0K | -1.342M | |
YoY Change | -56.34% | -130.99% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.030M | -$2.147M | |
Capital Expenditures | $0.00 | ||
Free Cash Flow | -$2.147M | ||
YoY Change | -10835.0% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001591890 | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022 | FGF |
Increase In Investment Without Readily Determinable Fair Value
IncreaseInInvestmentWithoutReadilyDeterminableFairValue
|
usd | |
CY2022 | FGF |
Increase In Fair Value Of Convertible Note
IncreaseInFairValueOfConvertibleNote
|
usd | |
CY2023 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
usd | |
CY2022 | us-gaap |
Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
|
usd | |
CY2022 | FGF |
Carrying Value Of Limited Liability Company Interests Received In Connection With Fg Special Situations Fund Unwind
CarryingValueOfLimitedLiabilityCompanyInterestsReceivedInConnectionWithFgSpecialSituationsFundUnwind
|
usd | |
CY2022 | FGF |
Equity Securities In Oppfi Received In Connection With Fg Special Situations Fund Unwind
EquitySecuritiesInOppfiReceivedInConnectionWithFgSpecialSituationsFundUnwind
|
usd | |
CY2022 | FGF |
Equity Securities In Icoreconnect Inc Received In Connection With Conversion Of Bridge Loan
EquitySecuritiesInIcoreconnectIncReceivedInConnectionWithConversionOfBridgeLoan
|
usd | |
CY2023 | us-gaap |
Debt Securities Trading Unrealized Loss
DebtSecuritiesTradingUnrealizedLoss
|
usd | |
CY2022 | us-gaap |
Debt Securities Trading Unrealized Gain
DebtSecuritiesTradingUnrealizedGain
|
usd | |
CY2022Q4 | us-gaap |
Other Notes Payable
OtherNotesPayable
|
usd | |
CY2023 | FGF |
Contributions In Investments Without Readily Determinable Fair Value
ContributionsInInvestmentsWithoutReadilyDeterminableFairValue
|
usd | |
CY2022 | FGF |
Increase Due To Change In Observable Price
IncreaseDueToChangeInObservablePrice
|
usd | |
CY2023 | FGF |
Income Tax Expense Benefit From Continuing And Discontinued Operations
IncomeTaxExpenseBenefitFromContinuingAndDiscontinuedOperations
|
usd | |
CY2023 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
pure | |
CY2022 | FGF |
Income Tax Expense Benefit From Continuing And Discontinued Operations
IncomeTaxExpenseBenefitFromContinuingAndDiscontinuedOperations
|
usd | |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
pure | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
usd | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
usd | |
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
001-36366 | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
Fundamental Global Inc. | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
46-1119100 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
108 Gateway Blvd | |
CY2023 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 204 | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Mooresville | |
CY2023 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NC | |
CY2023 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
28117 | |
CY2023 | dei |
City Area Code
CityAreaCode
|
(704) | |
CY2023 | dei |
Local Phone Number
LocalPhoneNumber
|
323-6851 | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
8213211 | usd |
CY2024Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
28369066 | shares |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
243 | |
CY2023 | dei |
Auditor Name
AuditorName
|
BDO USA, P.C. | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
Grand Rapids, Michigan | |
CY2023Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
1916000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
889000 | usd |
CY2023Q4 | us-gaap |
Equity Securities Fv Ni
EquitySecuritiesFvNi
|
4552000 | usd |
CY2022Q4 | us-gaap |
Equity Securities Fv Ni
EquitySecuritiesFvNi
|
841000 | usd |
CY2023Q4 | us-gaap |
Other Short Term Investments
OtherShortTermInvestments
|
26301000 | usd |
CY2022Q4 | us-gaap |
Other Short Term Investments
OtherShortTermInvestments
|
24839000 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2396000 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3010000 | usd |
CY2023Q4 | us-gaap |
Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
|
1660000 | usd |
CY2022Q4 | us-gaap |
Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
|
1527000 | usd |
CY2023Q4 | us-gaap |
Reinsurance Recoverables Allowance
ReinsuranceRecoverablesAllowance
|
96000 | usd |
CY2022Q4 | us-gaap |
Reinsurance Recoverables Allowance
ReinsuranceRecoverablesAllowance
|
0 | usd |
CY2023Q4 | us-gaap |
Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
|
21571000 | usd |
CY2022Q4 | us-gaap |
Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
|
9269000 | usd |
CY2023Q4 | FGF |
Funds Deposited For Benefit Of Reinsured Companies
FundsDepositedForBenefitOfReinsuredCompanies
|
8002000 | usd |
CY2022Q4 | FGF |
Funds Deposited For Benefit Of Reinsured Companies
FundsDepositedForBenefitOfReinsuredCompanies
|
9277000 | usd |
CY2023Q4 | us-gaap |
Other Assets
OtherAssets
|
1254000 | usd |
CY2022Q4 | us-gaap |
Other Assets
OtherAssets
|
712000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
65736000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
49475000 | usd |
CY2023Q4 | us-gaap |
Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
|
9016000 | usd |
CY2022Q4 | us-gaap |
Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
|
4409000 | usd |
CY2023Q4 | us-gaap |
Unearned Premiums
UnearnedPremiums
|
13476000 | usd |
CY2022Q4 | us-gaap |
Unearned Premiums
UnearnedPremiums
|
6823000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
206000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
723000 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
546000 | usd |
CY2022Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
225000 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
23244000 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
12180000 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
25.00 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
25.00 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
894580 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
894580 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
894580 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
894580 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
22365000 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
22365000 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
10558931 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
9410473 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
10558931 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
9410473 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
10000 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
9000 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
53264000 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
50021000 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-33147000 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-35100000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
42492000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
37295000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
65736000 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
49475000 | usd |
CY2023 | us-gaap |
Premiums Earned Net
PremiumsEarnedNet
|
16631000 | usd |
CY2022 | us-gaap |
Premiums Earned Net
PremiumsEarnedNet
|
12998000 | usd |
CY2023 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
9798000 | usd |
CY2022 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
6777000 | usd |
CY2023 | us-gaap |
Other Income
OtherIncome
|
413000 | usd |
CY2022 | us-gaap |
Other Income
OtherIncome
|
320000 | usd |
CY2023 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
26842000 | usd |
CY2022 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
20095000 | usd |
CY2023 | FGF |
Net Losses And Loss Adjustment Expenses
NetLossesAndLossAdjustmentExpenses
|
9713000 | usd |
CY2022 | FGF |
Net Losses And Loss Adjustment Expenses
NetLossesAndLossAdjustmentExpenses
|
7484000 | usd |
CY2023 | us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
3623000 | usd |
CY2022 | us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
3169000 | usd |
CY2023 | FGF |
General And Administrative Related Party Expense
GeneralAndAdministrativeRelatedPartyExpense
|
1825000 | usd |
CY2022 | FGF |
General And Administrative Related Party Expense
GeneralAndAdministrativeRelatedPartyExpense
|
1825000 | usd |
CY2023 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
9661000 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8354000 | usd |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
22997000 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
19007000 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
3845000 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
1088000 | usd |
CY2023 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
1786000 | usd |
CY2022 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
1789000 | usd |
CY2023 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
2059000 | usd |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-701000 | usd |
CY2023 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.21 | |
CY2023 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.21 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.09 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-0.09 | |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
9991980 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
9991980 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
8030106 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
8030106 | shares |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
34009000 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
255000 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3732000 | usd |
CY2022 | us-gaap |
Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
|
2.00 | |
CY2022 | FGF |
Dividends Declared On Series A Preferred Shares
DividendsDeclaredOnSeriesAPreferredShares
|
-1789000 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
1088000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
37295000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
37295000 | usd |
CY2023 | FGF |
Cumulative Effect Of Adoption Of Accounting Guidance For Expected Credit Losses
CumulativeEffectOfAdoptionOfAccountingGuidanceForExpectedCreditLosses
|
-106000 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
1964000 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1280000 | usd |
CY2023 | us-gaap |
Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
|
2.00 | |
CY2023 | FGF |
Dividends Declared On Series A Preferred Shares
DividendsDeclaredOnSeriesAPreferredShares
|
-1786000 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
3845000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
42492000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
42492000 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
3845000 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
1088000 | usd |
CY2023 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
2684000 | usd |
CY2022 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
13026000 | usd |
CY2023 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
3130000 | usd |
CY2022 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
7618000 | usd |
CY2023 | FGF |
Increase In Investment Without Readily Determinable Fair Value
IncreaseInInvestmentWithoutReadilyDeterminableFairValue
|
250000 | usd |
CY2023 | FGF |
Increase In Fair Value Of Convertible Note
IncreaseInFairValueOfConvertibleNote
|
125000 | usd |
CY2023 | us-gaap |
Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
|
3062000 | usd |
CY2022 | us-gaap |
Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
|
-13797000 | usd |
CY2023 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1964000 | usd |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
255000 | usd |
CY2023 | FGF |
Increase Decrease In Funds Deposited With Reinsured Companies
IncreaseDecreaseInFundsDepositedWithReinsuredCompanies
|
1275000 | usd |
CY2022 | FGF |
Increase Decrease In Funds Deposited With Reinsured Companies
IncreaseDecreaseInFundsDepositedWithReinsuredCompanies
|
-4835000 | usd |
CY2023 | us-gaap |
Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
|
12408000 | usd |
CY2022 | us-gaap |
Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
|
5416000 | usd |
CY2023 | us-gaap |
Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
|
133000 | usd |
CY2022 | us-gaap |
Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
|
741000 | usd |
CY2023 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
571000 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-114000 | usd |
CY2023 | us-gaap |
Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
|
4607000 | usd |
CY2022 | us-gaap |
Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
|
2276000 | usd |
CY2023 | us-gaap |
Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
|
6653000 | usd |
CY2022 | us-gaap |
Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
|
3213000 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-196000 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-129000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4215000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-11022000 | usd |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
81000 | usd |
CY2023 | us-gaap |
Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
|
495000 | usd |
CY2022 | us-gaap |
Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
|
8844000 | usd |
CY2023 | us-gaap |
Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
|
950000 | usd |
CY2023 | us-gaap |
Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
|
764000 | usd |
CY2022 | us-gaap |
Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
|
4544000 | usd |
CY2023 | us-gaap |
Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
|
4604000 | usd |
CY2022 | us-gaap |
Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
|
698000 | usd |
CY2023 | us-gaap |
Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
|
184000 | usd |
CY2022 | us-gaap |
Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
|
230000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
4107000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3453000 | usd |
CY2023 | us-gaap |
Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
|
1786000 | usd |
CY2022 | us-gaap |
Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
|
1789000 | usd |
CY2023 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
1280000 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
3732000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-506000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1943000 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-614000 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-12532000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
3010000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
15542000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
2396000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
3010000 | usd |
CY2023 | FGF |
Carrying Value Of Limited Liability Company Interests Received In Connection With Fg Special Situations Fund Unwind
CarryingValueOfLimitedLiabilityCompanyInterestsReceivedInConnectionWithFgSpecialSituationsFundUnwind
|
13754000 | usd |
CY2023 | FGF |
Equity Securities In Oppfi Received In Connection With Fg Special Situations Fund Unwind
EquitySecuritiesInOppfiReceivedInConnectionWithFgSpecialSituationsFundUnwind
|
1916000 | usd |
CY2023 | FGF |
Equity Securities In Icoreconnect Inc Received In Connection With Conversion Of Bridge Loan
EquitySecuritiesInIcoreconnectIncReceivedInConnectionWithConversionOfBridgeLoan
|
654000 | usd |
CY2023 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p id="xdx_808_eus-gaap--NatureOfOperations_z5HDrQzULdX" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fin6"></span>Note 1. <span id="xdx_825_zPGXULfXzmHf">Nature of Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fundamental Global Inc. (“FGF”, the “Company”, “we”, or “us”), formerly known as FG Financial Group, Inc., is a reinsurance, merchant banking and asset management holding company. We focus on opportunistic collateralized and loss capped reinsurance, while allocating capital to merchant banking activities. The Company’s principal business operations are conducted through its subsidiaries and affiliates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, FG Financial Holdings, LLC (“FG”), a private partnership focused on long-term strategic holdings, and its affiliated entity, collectively beneficially owned approximately <span id="xdx_90C_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20231231__srt--OwnershipAxis__custom--FGFinancialHoldingsLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmrYE96Fzy8l" title="Ownership percentage">54.6</span>% of our common stock. D. Kyle Cerminara, Chairman of our Board of Directors, serves as Chief Executive Officer, Co-Founder and Partner of FG.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reincorporation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective at 5:01 p.m. ET on December 9, 2022, the Company completed its reincorporation from a Delaware corporation to a Nevada corporation (the “Reincorporation”). The Reincorporation was accomplished by means of a merger by and between the Company and its former wholly owned subsidiary FG Financial Group, Inc., a Nevada corporation. As of December 9, 2022, the rights of the Company’s stockholders began to be governed by the Nevada corporation laws, our Amended and Restated Nevada Articles of Incorporation and our Nevada Bylaws. The Reincorporation was approved by the Company’s stockholders at a special meeting held on December 6, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other than the change in the state of incorporation, the Reincorporation did not result in any change in the business, physical location, management, assets, liabilities or net worth of the Company, nor did it result in any change in location of the Company’s employees, including the Company’s management.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Reincorporation did not alter any stockholder’s percentage ownership interest or number of shares owned in the Company and the Company’s common stock continues to be quoted on the Nasdaq Global Market under the same symbol “FGF” and the 8.00% Cumulative Preferred Stock, Series A of the Company continues to be quoted on the Nasdaq Global Market under the same symbol, “FGFPP.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Current Business</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our strategy has evolved to focus on opportunistic collateralized and loss capped reinsurance, with capital allocation to merchant banking activities with asymmetrical risk/reward opportunities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, the business operates as a diversified holding company of insurance, reinsurance, asset management, our Special purpose acquisition corporation “SPAC” Platform businesses, and our merchant banking division.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Insurance</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor Protection Coverage and Risk, Inc. has been formed as a special purpose captive in South Carolina to provide reinsurance coverage for Sides A, B, & C Directors and Officers Liability insurance coverage for related and unrelated entities of FG Reinsurance Ltd. (“FGRe”). These will include SPAC entities engaged in the services or business of taking companies public, as well as small cap businesses performing an initial public offering. Sponsor Protection Coverage and Risk, Inc. has yet to write any business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reinsurance</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly owned reinsurance subsidiary, FGRe, a Cayman Islands limited liability company, provides specialty property and casualty reinsurance. FGRe has been granted a Class B (iii) insurer license in accordance with the terms of The Insurance Act (as revised) of the Cayman Islands and underlying regulations thereto and is subject to regulation by the Cayman Islands Monetary Authority (the “Authority”). The terms of the license require advance approval from the Authority should FGRe wish to enter into any reinsurance agreements which are not fully collateralized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the Company had <span id="xdx_901_ecustom--NumberOfActiveReinsuranceContracts_iI_dc_uInteger_c20231231_zQwJ2JYLQNb2" title="Number of active reinsurance contracts">eight</span> active reinsurance contracts, including participating in a Funds at Lloyds (“FAL”) syndicate covering risks written by the syndicate during the 2021, 2022 and 2023 calendar years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, during 2023, the Company began to focus on growing fee-based revenue through FG Re Solutions, Ltd.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Asset Management</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FG Strategic Consulting, LLC, (“FGSC”) a wholly-owned subsidiary of the Company, provides investment advisory services, including identifying, analyzing and recommending potential investments, advising as to existing investments and investment optimization, recommending investment dispositions, and providing advice regarding macro-economic conditions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>SPAC Platform and Merchant Banking</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 21, 2020, we formed FG Management Solutions LLC (“FGMS”), formerly known as FG SPAC Solutions, LLC, a Delaware company, to facilitate the launch of our “SPAC Platform.” Under the SPAC Platform, we provide various strategic, administrative, and regulatory support services to newly formed SPACs for a monthly fee. Additionally, the Company co-founded a partnership, FG Merchant Partners, LP (“FGMP”), formerly known as FG SPAC Partners, LP, to participate as a co-sponsor for newly formed SPACs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the third quarter of 2022, the Company announced the expansion of its growth strategy through the formation of a merchant banking division.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the fourth quarter of 2022, the Company invested $<span id="xdx_906_eus-gaap--Investments_iI_pn5n6_c20221231__dei--LegalEntityAxis__custom--FGCommunitiesIncMember_zpxHPAV8Day5" title="Investments">2.0</span> million into its first merchant banking project, FG Communities, Inc. (“FGC”). FGC is a self-managed real estate company focused on a growing portfolio of manufactured housing communities which are owned and operated by FGC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2023Q4 | FGF |
Number Of Active Reinsurance Contracts
NumberOfActiveReinsuranceContracts
|
8 | integer |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84D_eus-gaap--UseOfEstimates_zTigH7xDZ5ke" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_z0ffEhw4IEwe">The Use of Estimates in the Preparation of Consolidated Financial Statements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the application of policies and the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses for the reporting period. Actual results could differ from these estimates. Estimates and their underlying assumptions are reviewed on an ongoing basis. Changes in estimates are recorded in the accounting period in which they are determined. The significant estimates in the accompanying consolidated financial statements include the valuation of our other investments, the valuation of net deferred income taxes, premium revenue recognition, and reserves for loss and loss adjustment expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2023Q4 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.20 | pure |
CY2023Q4 | us-gaap |
Cash
Cash
|
200000 | usd |
CY2023 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zegjv5KHqubi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zpgebZOKxlga">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments which potentially expose the Company to concentrations of credit risk include investments, cash, and deposits with reinsured companies. The Company maintains its cash with a major U.S. domestic banking institution which is insured by the Federal Deposit Insurance Corporation (“FDIC”) for up to $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20231231_z52S1kds0Nkk" title="Cash FDIC insured amount">250,000</span>. As of December 31, 2023, the Company held funds in excess of these FDIC insured amounts. The terms of these deposits are on demand to mitigate some of the associated risk. The Company has not incurred losses related to these deposits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2023Q4 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | usd |
CY2023Q1 | us-gaap |
Cumulative Earnings Deficit
CumulativeEarningsDeficit
|
100000 | usd |
CY2023Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
100000 | usd |
CY2023Q4 | us-gaap |
Investments
Investments
|
450000 | usd |
CY2023Q4 | us-gaap |
Securities Purchased Under Agreements To Resell Amount Offset Against Collateral
SecuritiesPurchasedUnderAgreementsToResellAmountOffsetAgainstCollateral
|
8000000.0 | usd |
CY2022Q4 | us-gaap |
Securities Purchased Under Agreements To Resell Amount Offset Against Collateral
SecuritiesPurchasedUnderAgreementsToResellAmountOffsetAgainstCollateral
|
9300000 | usd |
CY2023Q1 | us-gaap |
Cumulative Earnings Deficit
CumulativeEarningsDeficit
|
100000 | usd |
CY2023Q4 | us-gaap |
Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
|
1916000 | usd |
CY2023 | us-gaap |
Debt Securities Trading Unrealized Gain
DebtSecuritiesTradingUnrealizedGain
|
2636000 | usd |
CY2023Q4 | us-gaap |
Trading Securities Debt
TradingSecuritiesDebt
|
4552000 | usd |
CY2022Q4 | us-gaap |
Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
|
889000 | usd |
CY2022 | us-gaap |
Debt Securities Trading Unrealized Loss
DebtSecuritiesTradingUnrealizedLoss
|
48000 | usd |
CY2022Q4 | us-gaap |
Trading Securities Debt
TradingSecuritiesDebt
|
841000 | usd |
CY2023Q1 | us-gaap |
Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
|
16000 | shares |
CY2023Q4 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
23532000 | usd |
CY2022Q4 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
22586000 | usd |
CY2023Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
2319000 | usd |
CY2022Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
2253000 | usd |
CY2023Q4 | us-gaap |
Other Notes Payable
OtherNotesPayable
|
450000 | usd |
CY2023Q4 | us-gaap |
Other Short Term Investments
OtherShortTermInvestments
|
26301000 | usd |
CY2022Q4 | us-gaap |
Other Short Term Investments
OtherShortTermInvestments
|
24839000 | usd |
CY2023 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
|
300000 | usd |
CY2022 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
|
0 | usd |
CY2022Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
2253000 | usd |
CY2021Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
483000 | usd |
CY2022 | FGF |
Contributions In Investments Without Readily Determinable Fair Value
ContributionsInInvestmentsWithoutReadilyDeterminableFairValue
|
2000000 | usd |
CY2023 | FGF |
Distributions From Investments Without Readily Determinable Fair Value
DistributionsFromInvestmentsWithoutReadilyDeterminableFairValue
|
184000 | usd |
CY2022 | FGF |
Distributions From Investments Without Readily Determinable Fair Value
DistributionsFromInvestmentsWithoutReadilyDeterminableFairValue
|
230000 | usd |
CY2023 | FGF |
Increase Due To Change In Observable Price
IncreaseDueToChangeInObservablePrice
|
250000 | usd |
CY2023Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
2319000 | usd |
CY2022Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
2253000 | usd |
CY2023 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
9798000 | usd |
CY2022 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
6777000 | usd |
CY2021Q4 | us-gaap |
Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
|
4338000 | usd |
CY2022Q4 | us-gaap |
Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
|
7484000 | usd |
CY2023Q4 | us-gaap |
Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
|
9713000 | usd |
CY2023Q4 | us-gaap |
Reinsurance Receivables Incurred But Not Reported Claims
ReinsuranceReceivablesIncurredButNotReportedClaims
|
6270000 | usd |
CY2021Q4 | us-gaap |
Reinsurance Recoverables On Paid Losses
ReinsuranceRecoverablesOnPaidLosses
|
2205000 | usd |
CY2022Q4 | us-gaap |
Reinsurance Recoverables On Paid Losses
ReinsuranceRecoverablesOnPaidLosses
|
5208000 | usd |
CY2023Q4 | us-gaap |
Reinsurance Recoverables On Paid Losses
ReinsuranceRecoverablesOnPaidLosses
|
5106000 | usd |
CY2023Q4 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Reported Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount
|
9016000 | usd |
CY2022Q4 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Reported Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount
|
4409000 | usd |
CY2023Q4 | us-gaap |
Reinsurance Recoverables On Paid And Unpaid Losses
ReinsuranceRecoverablesOnPaidAndUnpaidLosses
|
9016000 | usd |
CY2022Q4 | us-gaap |
Reinsurance Recoverables On Paid And Unpaid Losses
ReinsuranceRecoverablesOnPaidAndUnpaidLosses
|
4409000 | usd |
CY2023 | us-gaap |
Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
|
<p id="xdx_896_eus-gaap--ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_zd9EbtvtriW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of changes in outstanding loss and loss adjustment expense reserves for the years ended December 31, 2023 and 2022 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BE_zkpgWR4H1Szd" style="display: none">Schedule of Changes in Outstanding Loss Adjustment Expense Reserves</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td>(in thousands)</td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20230101__20231231_zhxCHxqvcnb3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31, 2023</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" id="xdx_49A_20220101__20221231_z6j1AabEZ8Me" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td> </td></tr> <tr id="xdx_407_eus-gaap--ReinsuranceRecoverables_iS_pn3n3_zLRGz460aZp6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Balance, January 1</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">4,409</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,133</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Incurred related to:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ReinsuranceLossOnUncollectibleAccountsInPeriodAmount_pn3n3_zz8YWUK7XsD9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current year</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,487</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,628</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--ReinsuranceLossOnUncollectibleAccountsInPriorPeriodAmount_pn3n3_zNxtveuD7I78" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prior years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,226</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">856</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Paid related to:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ReinsuranceRecoverableCreditLossExpenseReversal_pn3n3_zhN0MIQk0ffh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Current year</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,803</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,822</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_ecustom--ReinsuranceRecoverableCreditLossExpenseReversalPriorYear_pn3n3_zEFUGa6NZoOc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Prior years</td><td style="font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-style: normal; font-weight: normal">(1,303</span></td><td style="font-weight: bold; text-align: left"><span style="font-style: normal; font-weight: normal">)</span></td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,386</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--ReinsuranceRecoverables_iE_pn3n3" style="vertical-align: bottom; background-color: White"> <td>Balance, December 31</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9,016</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4,409</td><td style="text-align: left"> </td></tr> </table> | |
CY2022Q4 | us-gaap |
Reinsurance Recoverables
ReinsuranceRecoverables
|
4409000 | usd |
CY2021Q4 | us-gaap |
Reinsurance Recoverables
ReinsuranceRecoverables
|
2133000 | usd |
CY2023 | us-gaap |
Reinsurance Loss On Uncollectible Accounts In Period Amount
ReinsuranceLossOnUncollectibleAccountsInPeriodAmount
|
8487000 | usd |
CY2022 | us-gaap |
Reinsurance Loss On Uncollectible Accounts In Period Amount
ReinsuranceLossOnUncollectibleAccountsInPeriodAmount
|
6628000 | usd |
CY2023 | FGF |
Reinsurance Loss On Uncollectible Accounts In Prior Period Amount
ReinsuranceLossOnUncollectibleAccountsInPriorPeriodAmount
|
1226000 | usd |
CY2022 | FGF |
Reinsurance Loss On Uncollectible Accounts In Prior Period Amount
ReinsuranceLossOnUncollectibleAccountsInPriorPeriodAmount
|
856000 | usd |
CY2023 | us-gaap |
Reinsurance Recoverable Credit Loss Expense Reversal
ReinsuranceRecoverableCreditLossExpenseReversal
|
-3803000 | usd |
CY2022 | us-gaap |
Reinsurance Recoverable Credit Loss Expense Reversal
ReinsuranceRecoverableCreditLossExpenseReversal
|
-3822000 | usd |
CY2023 | FGF |
Reinsurance Recoverable Credit Loss Expense Reversal Prior Year
ReinsuranceRecoverableCreditLossExpenseReversalPriorYear
|
-1303000 | usd |
CY2022 | FGF |
Reinsurance Recoverable Credit Loss Expense Reversal Prior Year
ReinsuranceRecoverableCreditLossExpenseReversalPriorYear
|
-1386000 | usd |
CY2023Q4 | us-gaap |
Reinsurance Recoverables
ReinsuranceRecoverables
|
9016000 | usd |
CY2022Q4 | us-gaap |
Reinsurance Recoverables
ReinsuranceRecoverables
|
4409000 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
807000 | usd |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | pure |
CY2022 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
229000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | pure |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | pure |
CY2023 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-832000 | usd |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.217 | pure |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-252000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.231 | pure |
CY2023 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
25000 | usd |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.007 | pure |
CY2022 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
23000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.021 | pure |
CY2023Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
8500000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
3800000 | usd |
CY2023 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
4700000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
5117000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
4171000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
|
70000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
|
39000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve
|
566000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve
|
287000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
|
2377000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
|
4313000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
294000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
242000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
|
1000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
|
5000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
30000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
9000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
8455000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
9066000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
4654000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
5463000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
3801000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
3603000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
|
3453000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
|
3282000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost
DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost
|
348000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost
DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost
|
321000 | usd |
CY2023Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
3801000 | usd |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
3603000 | usd |
CY2023Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
24400000 | usd |
CY2023Q1 | FGF |
Employee Stock Purchase Plan Addition Description
EmployeeStockPurchasePlanAdditionDescription
|
the board of directors approved an employee purchase plan (“ESPP Plan”) whereby qualifying employees can choose each year to have up to 5% of their annual base earnings withheld to purchase the Company’s common shares in the open market. The Company matches 100% of the employee’s contribution amount after twelve months of employment | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.4560 | pure |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P10Y | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0115 | pure |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | pure |
CY2023 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
2000000.0 | usd |
CY2022 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
255000 | usd |
CY2023Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
1300000 | usd |
CY2023Q2 | us-gaap |
Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
|
865000 | shares |
CY2023Q2 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
1.85 | |
CY2023Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
1300000 | usd |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
10558931 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
9410473 | shares |
CY2023 | us-gaap |
Description Of Regulatory Capital Requirements Under Insurance Regulations
DescriptionOfRegulatoryCapitalRequirementsUnderInsuranceRegulations
|
In accordance with the terms of The Insurance Regulations, as a Class B(iii)insurer under the Act, the Company is required to maintain a minimum capital of $200,000 and a prescribed capital of $1,622,324 in line with the Regulations based on 15% of the first $5 million in net earned premium and 7.5% of additional net earned premium up to $20,000,000. The Company was in compliance with these requirements as of December 31, 2023 | |
CY2023 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
3845000 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
1088000 | usd |
CY2023 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
1786000 | usd |
CY2022 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
1789000 | usd |
CY2023 | us-gaap |
Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
|
2059000 | usd |
CY2022 | us-gaap |
Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
|
-701000 | usd |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
9991980 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
8030106 | shares |
CY2023 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.21 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.09 | |
CY2023 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1176108 | shares |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
411382 | shares |
CY2023 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
|
1 | pure |
CY2023 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
|
0.03 | pure |
CY2023 | FGF |
Percentage Of Additional Contribution Matched By Employer
PercentageOfAdditionalContributionMatchedByEmployer
|
0.50 | pure |
CY2023 | FGF |
Additional Limited Contributions By Employees Employer Match
AdditionalLimitedContributionsByEmployeesEmployerMatch
|
0.02 | pure |
CY2023 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
26000 | usd |
CY2022 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
44000 | usd |
CY2023Q1 | FGF |
Employee Stock Purchase Plan Description
EmployeeStockPurchasePlanDescription
|
the board of directors approved an employee purchase plan (“ESPP Plan”) whereby qualifying employees can choose each year to have up to 5% of their annual base earnings withheld to purchase the Company’s common shares in the open market. The Company matches 100% of the employee’s contribution amount after thirty days of employment | |
CY2023 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
18000 | usd |
CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
0 | usd |
CY2022Q2 | us-gaap |
Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
|
0.08 | pure |
CY2023Q4 | FGF |
Operating Asset And Lease Liability
OperatingAssetAndLeaseLiability
|
39000 | usd |
CY2022Q4 | FGF |
Operating Asset And Lease Liability
OperatingAssetAndLeaseLiability
|
56000 | usd |
CY2023 | us-gaap |
Payments For Rent
PaymentsForRent
|
15000 | usd |
CY2022 | us-gaap |
Payments For Rent
PaymentsForRent
|
17000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
21000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
21000 | usd |
CY2023Q4 | FGF |
Lessee Operating Lease Liability Imputed Interest Net Amount
LesseeOperatingLeaseLiabilityImputedInterestNetAmount
|
3000 | usd |
CY2023Q4 | FGF |
Operating Asset And Lease Liability
OperatingAssetAndLeaseLiability
|
39000 | usd |
CY2023 | us-gaap |
Premiums Earned Net
PremiumsEarnedNet
|
16631000 | usd |
CY2023 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
9798000 | usd |
CY2023 | us-gaap |
Other Income
OtherIncome
|
413000 | usd |
CY2023 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
26842000 | usd |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
3845000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
65736000 | usd |
CY2022 | us-gaap |
Premiums Earned Net
PremiumsEarnedNet
|
12998000 | usd |
CY2022 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
6777000 | usd |
CY2022 | us-gaap |
Other Income
OtherIncome
|
320000 | usd |
CY2022 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
20095000 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1088000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
49475000 | usd |